Observational Study
Copyright ©The Author(s) 2022.
World J Hepatol. Mar 27, 2022; 14(3): 612-622
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.612
Table 2 Demographic, lifestyle and general health comorbidities of participants according to the presence of depression and nonalcoholic fatty liver disease

Individuals with NAFLD
Individuals without NAFLD

No depression (n = 207)
Depression (n = 28)
P value
No depression (n = 327)
Depression (n = 27)
P value
Age, mean ± SD59.91 ± 6.3460.15 ± 6.000.943360.02 ± 7.3259.61 ± 8.440.9813
Male, %115 (55.56%)8 (28.57%)0.0073125 (38.23%)6 (22.22%)0.0978
White, %197 (95.17%)27 (96.43%)0.7671316 (96.64%)24 (88.89%)0.0471
Smoking status, %
Current19 (9.18%)4 (14.29%)0.393441 (12.58%)6 (22.22%)0.1563
Former86 (41.55%)12 (42.86%)0.8949133 (40.80%)8 (29.63%)0.2549
Non-smoker102 (49.28%)12 (42.86%)0.5236152 (46.63%)13 (48.15%)0.8789
Regular exercise, %
Physically inactive69 (33.33%)17 (60.71%)0.004875 (22.94%)10 (37.04%)0.0992
Moderate physical activity86 (41.55%)5 (17.86%)0.0157129 (39.45%)10 (37.04%)0.8051
Ideal physical activity52 (25.12%)6 (21.43%)0.6706123 (37.61%)7 (25.93%)0.2259
Obesity, % BMI
Lean13 (6.28%)2 (7.14%)0.8609232 (70.95%)23 (85.19%)0.1132
Overweight118 (57.00%)17 (60.71%)0.709495 (29.05%)4 (14.81%)0.1132
Obese76 (36.71%)9 (32.14%)0.63650 (0.00%)0 (0.00%)-------
History of CVD, %14 (6.76%)3 (10.71%)0.448821 (6.42%)2 (7.41%)0.8417
History of arthritis, %21 (10.14%)8 (28.57%)0.005437 (11.31%)2 (7.41%)0.5331
History of any cancer, %46 (22.22%)3 (10.71%)0.159547 (14.37%)1 (3.70%)0.1196
Insulin resistance, %97 (46.86%)12 (42.86%)0.690247 (14.37%)1 (3.70%)0.1196
Hypertension, %44 (21.26%)7 (25.00%)0.651961 (18.65%)5 (18.52%)0.9861
Hyperlipidemia, %177 (85.51%)24 (85.71%)0.9767226 (69.11%)19 (70.37%)0.8918
Diabetes, %50 (24.15%)5 (17.86%)0.460116 (4.89%)3 (11.11%)0.1682
Metabolic syndrome1, %91 (43.96%)11 (39.29%)0.639421 (6.44%)2 (7.41%)0.8451